Based on the company's latest reports for March 2026, the current 12-month EPS is $18.36. Chemed's earnings per share in 2025 was reported at $18.42, marking a decrease from $20.1 in 2024. In the quarterly report ending on Mar 31, 2026, CHE's earnings per share amounted to $4.85.
Chemed had an yealy earnings per share of $18.42, showing a decrease of 8.4% from $20.1 recorded in 2024. The quarterly earnings per share for the period ending Mar 31, 2026, was $4.85, showing a 1.2% decline compared to the same quarter last year. The trailing twelve months EPS for CHE is $18.36 as of March 2026. Chemed's full-year EPS for 2024 was $20.1, a 11% rise compared to the previous year.
Over the past 12 months, Chemed has recorded an earnings per share growth rate of -1.2% (YoY, quarterly). Across the past three years, the company had an average EPS annual growth rate of 3.3% per year. In the last five years, the company had an average annual EPS growth of -1.7%. When assessed over a ten-year period, CHE's average EPS annual growth was 10.9%.
| Stock name | Price to Earnings | EPS grwoth 1Y | EPS grwoth 3Y | EPS grwoth 5Y |
|---|---|---|---|---|
| RPM Rpm International Inc | 20 | 17.5% | 12.2% | 18% |
| CHE Chemed Corp | 23.55 | -8.4% | 3.3% | -1.7% |
| BCPC Balchem Corp | 32.1 | 20.9% | 13.4% | 12.8% |
| SXT Sensient Technologies Corp | 33.18 | 7.4% | -1.8% | 4.2% |
All data is based on quarterly TTM periods, unless otherwise specified.